A possible Guillain-Barre syndrome/transverse myelitis overlap syndrome after recent COVID-19

被引:9
作者
Alrubaye, Riyadh [1 ]
Bondugula, Vijayamala [2 ]
Baleguli, Vidya [3 ]
Chofor, Rosemary [4 ]
机构
[1] Northeast Georgia Hlth Syst Inc, Dept Hosp Med, Internal Med Residency Program, Gainesville, GA 30501 USA
[2] Northeast Georgia Hlth Syst Inc, Dept Neurol, Gainesville, GA USA
[3] Northeast Georgia Hlth Syst Inc, Dept GME Internal Med, Gainesville, GA USA
[4] Northeast Georgia Hlth Syst Inc, Dept GME, Internal Med Residency Program, Gainesville, GA USA
关键词
COVID-19; infection (neurology); neuroimaging; neuromuscular disease; spinal cord; TRANSVERSE MYELITIS;
D O I
10.1136/bcr-2021-246967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurological manifestations are common in SARS-CoV-2 infection, including life-threatening acute muscle weakness, due to neuromuscular disorders such as acute transverse myelitis (TM) and Guillain-Barre syndrome (GBS). These syndromes can rarely coexist and present as an overlap syndrome. Here, we report a patient who developed acute symmetrical proximal lower limb weakness 5 days after diagnosis of COVID-19. GBS was diagnosed due to the presence of motor signs, albumin-cytological dissociation in cerebrospinal fluid examination and axonal damage according to nerve condition tests. However, abnormal areas on MRI of the thoracic spine and lack of improvement with intravenous immunoglobulin supported a diagnosis of TM. Therefore, a possible overlap between GBS and TM was established. To our knowledge, this is the third case report of GBS/TM overlap syndrome after COVID-19. The patient's full and rapid recovery with intravenous corticosteroids and plasmapheresis supports our diagnosis.
引用
收藏
页数:4
相关论文
共 17 条
  • [1] Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
    Abu-Rumeileh, Samir
    Abdelhak, Ahmed
    Foschi, Matteo
    Tumani, Hayrettin
    Otto, Markus
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (04) : 1133 - 1170
  • [2] Proposed diagnostic criteria and nosology of acute transverse myelitis
    Barnes, G
    Benjamin, S
    Bowen, JD
    Cutter, N
    de Lateur, BJ
    Dietrich, WD
    Dowling, MM
    Griffin, JW
    Hummers, L
    Irani, D
    Jorens, PG
    Kaplin, AI
    Katz, JD
    Kerr, DA
    Krishnan, C
    Levy, CE
    Lucchinetti, C
    Lynn, DJ
    Mandler, RN
    McArthur, JC
    McDonald, JW
    Morrison, L
    Pardo-Villamizar, C
    Pidcock, FS
    Ransohoff, R
    Roos, KL
    Trovato, MK
    Vollmer, TL
    Wegener, ST
    Weinshenker, BG
    Wingerchuk, DM
    [J]. NEUROLOGY, 2002, 59 (04) : 499 - 505
  • [3] Carrillo-Larco Rodrigo M, 2020, Wellcome Open Res, V5, P107, DOI 10.12688/wellcomeopenres.15987.2
  • [4] Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barre syndrome
    Galassi, Giuliana
    Marchioni, Alessandro
    [J]. ACTA NEUROLOGICA BELGICA, 2020, 120 (05) : 1067 - 1075
  • [5] MRI in Transverse Myelitis
    Goh, Christine
    Desmond, Patricia M.
    Phal, Pramit M.
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2014, 40 (06) : 1267 - 1279
  • [6] Clinical features and prognosis of patients with Guillain-Barre and acute transverse myelitis overlap syndrome
    Guo, Fang
    Zhang, Yong-Bo
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 181 : 127 - 132
  • [7] Inam SHA., 2021, ANN INT MED DENT RES
  • [8] Concurrent Longitudinally Extensive Transverse Myelitis and Guillain-Barre Syndrome in a Child Secondary to COVID-19 Infection A Severe Neuroimmunologic Complication of COVID-19
    Khera, Daisy
    Didel, Siyaram
    Panda, Samhita
    Tiwari, Sarbesh
    Singh, Kuldeep
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (06) : E236 - E239
  • [9] Neurological side effects of checkpoint inhibitors
    Knauss, S.
    Roque, L. Ginesta
    Huehnchen, P.
    Heinzerling, L.
    Boehmerle, W.
    Endres, M.
    [J]. NERVENARZT, 2019, 90 (02): : 138 - 147
  • [10] Manam Rupesh, 2018, Cureus, V10, pe3371, DOI 10.7759/cureus.3371